Calibrating parametric subject-specific risk estimation
From MaRDI portal
Publication:3585402
DOI10.1093/biomet/asq012zbMath1205.62161OpenAlexW2024016305WikidataQ36142850 ScholiaQ36142850MaRDI QIDQ3585402
Tianxi Cai, L. Tian, Scott D. Solomon, L. J. Wei, Hajime Uno
Publication date: 19 August 2010
Published in: Biometrika (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc3412577
survival analysisCox modelrisk indexROC analysisnonparametric functional estimationcardiovascular diseases
Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50) Estimation in survival analysis and censored data (62N02)
Related Items
Robust dynamic risk prediction with longitudinal studies, Incorporating short‐term outcome information to predict long‐term survival with discrete markers, Bootstrapping Aalen-Johansen processes for competing risks: handicaps, solutions, and limitations, Landmark Prediction of Long-Term Survival Incorporating Short-Term Event Time Information, Frailty Models for Familial Risk With Application to Breast Cancer, Estimating Subject-Specific Dependent Competing Risk Profile with Censored Event Time Observations, Performance guarantees for individualized treatment rules, Subgroup specific incremental value of new markers for risk prediction, On the restricted mean survival time curve in survival analysis, Evaluating incremental values from new predictors with net reclassification improvement in survival analysis, Landmark Estimation of Survival and Treatment Effect in a Randomized Clinical Trial, Subgroup Specific Incremental Value of New Markers for Risk Prediction, Evaluating Incremental Values from New Predictors with Net Reclassification Improvement in Survival Analysis, Weak Convergence of the Wild Bootstrap for the Aalen-Johansen Estimator of the Cumulative Incidence Function of a Competing Risk, Estimating Individualized Treatment Rules Using Outcome Weighted Learning, Landmark estimation of survival and treatment effects in observational studies
